p53 is often accumulated in advanced ccRCC stages and accumulation of p53 has been linked to a shorter cancer-specific- (CSS) and recurrence-free-survival (PFI) (Noon et al. 2010; Shvarts et al. 2005). This evidence concerns the gene TP53 and nonpapillary renal cell carcinoma.